Posts Tagged ‘Inova Translational Medicine Institute’
The Importance of Infants’ Exposure to Micro-Organisms, New York Times
Many studies have strongly suggested that the trillions of microorganisms that inhabit the human body influence our current and future health and may account for the rising incidence of several serious medical conditions now plaguing Americans, young and old. Dr. Suchitra Hourigan, a pediatric gastroenterologist and director of the Inova Translational Medicine Institute in Falls…
Read MoreC-Suite Awards: Aaron Black, Inova Translational Medicine Institute, Washington Business Journal
On the surface, the goals of personalized medicine, widely considered the future of medicine, are quite clear. Put patients into groups based on their genomic makeup, give doctors an edge in identifying potential threats, and shift from reactive to preventive treatment. But collecting and analyzing the data that drives this industry is inherently complex, and Aaron…
Read MoreImmunotherapy: Cancer Care Gets Customized
Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics. Tiffani A. DeMarco, MS, CGC, is a board-certified…
Read MoreInova Translational Medicine Institute Deploys Cloudera Bio-IT World
Inova Translational Medicine Institute today announced that it has deployed Cloudera Enterprise to securely analyze massive collections of clinical and genomic data at unprecedented speeds and scale for faster innovations in translational medicine research. Read more.
Read MoreInova: Uncovering Breakthrough Insights that Help Save Lives Cloudera
With Cloudera Enterprise, Inova researchers can answer questions magnitudes faster than they could previously to help the organization realize its goal of delivering precision medicine. Watch more.
Read MoreInova Translational Medicine Receives $9.5M Award from NIH to Study Environmental Influences on Child Health
Grant is part of a larger consortium award led by the Icahn School of Medicine at Mount Sinai Medical Center Falls Church, VA – October 3, 2016 – Inova Health System announced that the Inova Translational Medicine Institute (ITMI) has been awarded a $9.5M grant from the National Institutes of Health (NIH) to study environmental…
Read MoreInova Genome News: We’ve Come a Long Way
January 2016 The First 1000 Days of Life…and Beyond Study We’ve Come a Long Way Hello Families of the Inova Translational Medicine Institute (ITMI) “The First 1000 Days of Life…and Beyond” study. This newsletter is the first to celebrate the enrollment of 2,500 families and the third birthdays of our oldest participants. We will be…
Read MoreGovernor McAuliffe Announces Strategic Partnership Between Inova and George Mason University to Advance Personalized Medicine Translational Research
FALLS CHURCH, VA – Today Governor Terry McAuliffe announced a strategic partnership between Inova, the largest health system in Northern Virginia, and George Mason University, the largest public research university in Virginia, to conduct translational research and share resources for the benefit of patients, the community and the region. This collaboration will advance Inova’s personalized…
Read MoreFairfax Neonatal Associates and Inova Translational Medicine Institute announce partnership to Study the Causes of Preterm Birth
FALLS CHURCH, Virginia – October 9, 2015 – Fairfax Neonatal Associates (FNA) and the Inova Translational Medicine Institute (ITMI) today announced a partnership to study the causes of preterm birth. This partnership combines FNA’s expertise in neonatology, specifically including the clinical care of infants admitted to the Neonatal Intensive Care Unit of Inova Children’s Hospital…
Read MoreInova Names Todd Stottlemyer as CEO, Inova Center for Personalized Health
FALLS CHURCH, VA – June 30, 2015 – Inova today announced that Todd Stottlemyer has been named Chief Executive Officer, Inova Center for Personalized Health (ICPH). In this role, Stottlemyer will be responsible for developing and growing all activities on the 117-acre ICPH campus (formerly the ExxonMobil site in Falls Church) which includes the Inova Dwight…
Read More